Nat 2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patients.
dc.contributor.author | Werely CJ | |
dc.contributor.author | Donald PR | |
dc.contributor.author | Van Helden PD | |
dc.date.accessioned | 2012-08-10T16:52:00Z | |
dc.date.available | 2012-08-10T16:52:00Z | |
dc.date.issued | 2007 | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.description | Geneeskunde | |
dc.description | Molekulêre Biologie & Mensgenetika | |
dc.identifier.uri | http://hdl.handle.net/10019.1/40336 | |
dc.publisher | Personalized Medicine | |
dc.title | Nat 2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patients. | |
dc.type | Journal Articles (NON-subsidised) |